EU won't up stem cell funding

Even as commission research budget doubles, Potocnik won't seek to increase funding directly

Written byNed Stafford
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Despite a doubling in the European Commission's research funding for the coming years, the Commissioner for Science and Research will not seek directly to increase European Union funding for human embryonic stem cell research from current low levels, his spokeswoman has told The Scientist.

At a Brussels press conference earlier this month, the commissioner, Janez Potočnik, unveiled the European's Commission's proposed Seventh EU Research Framework Programme 2007–2013, which will allocate €67.8 billion (USD $88.4 billion)—just under €10 billion a year, double current annual funding levels—for research.

In December, Potočnik told a German newspaper that scientists in European nations should be allowed to use surplus human embryos to create stem cells for research purposes. However, Potočnik has since toned down his enthusiasm, and spokeswoman Antonia Mochan said that funding guidelines in Framework Programme 7, or FP7, would remain exactly the same as in the Sixth EU Research Framework Programme (FP6) 2002–2006. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform